Original paper
Abstract 3534: Analytical performance of a comprehensive genomic profiling system to detect actionable genetic alterations in NSCLC
Abstract
Background Comprehensive genomic profiling in NSCLC has become increasingly important for clinical management of advanced stage patients. Alteration status of EGFR, ALK, BRAF, and ROS1 are validated biomarkers linked to approved drugs, with many clinical trials enrolling on the basis of additional biomarkers, including Tumor Mutation Burden (TMB). It is therefore important to develop accurate and sensitive tools for tumor profiling, particularly...
Paper Details
Title
Abstract 3534: Analytical performance of a comprehensive genomic profiling system to detect actionable genetic alterations in NSCLC
Published Date
Jul 1, 2019
Journal
Volume
79
Issue
13_Supplement
Pages
3534 - 3534
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History